Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial
Titel:
Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial
Auteur:
Vergote, Ignace Scambia, Giovanni O'Malley, David M Van Calster, Ben Park, Sang-Yoon del Campo, Josep M Meier, Werner Bamias, Aristotelis Colombo, Nicoletta Wenham, Robert M Covens, Al Marth, Christian Raza Mirza, Mansoor Kroep, Judith R Ma, Haijun Pickett, Cheryl A Monk, Bradley J